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Abstract
Although fatal and non-fatal overdoses represent a significant source of morbidity and mortality,
current systems of surveillance and communication in Canada provide inadequate measurement of
drug trends and lack a timely response to drug-related hazards. In order for an effective early
warning system for illicit drug overdoses to become a reality, a number of elements will be
required: real-time epidemiologic surveillance systems for illicit drug trends and overdoses, inter-
agency networks for gathering data and disseminating alerts, and mechanisms for effectively and
respectfully engaging with members of drug using communities. An overdose warning system in an
urban area like Vancouver would ideally be imbedded within a system that monitors drug trends
and overdoses by incorporating qualitative and quantitative information obtained from multiple
sources. Valuable information may be collected and disseminated through community organizations
and services associated with public health, emergency health services, law enforcement, medical
laboratories, emergency departments, community-based organizations, research institutions and
people with addiction themselves. The present paper outlines considerations and conceptual
elements required to guide implementation of such systems in Canadian cities such as Vancouver.
Background
Illicit drug use in Canada is responsible for significant
costs – both in terms of human life and healthcare
resources [1,2]. The number of injection drug users alone
has been estimated at 60,000–90,000 in Canada [3] and
overdoses are a major cause of death in this group [3-5].
Studies indicate that drug users commonly experience and
witness drug overdoses [6-8]. However, the current drug
information systems provide inadequate measurement of
illicit drug trends and lack the ability to detect problems
and initiate a timely response to drug-related hazards such
as overdoses. The present paper outlines considerations
and conceptual elements for improved systems. The pro-
posed approach pushes beyond distal epidemiological
monitoring of drug trends by emphasizing a very proxi-
mal threat to public health, overdose. In this way, over-
dose functions as both an important indicator within drug
surveillance systems as well as a health outcome requiring
timely communication, intervention and preventative
strategies.
Discussion
The Substantial Risks and Repercussions of Drug Overdose
In addition to the tragedy of overdose fatality, non-fatal
overdoses amongst people with addiction users occur fre-
quently and have been associated with high morbidity.
Direct morbidity with heroin for example can include:
peripheral neuropathy, gastro-intestinal problems, tem-
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porary paralysis in limbs, chest infections, and seizures
while indirect complications may include physical injury
due to falls, burns, and assault [7]. Factors commonly
associated with increased overdose risk are: combining
heroin with other central nervous system depressants such
as alcohol [9], altered tolerance such as a period of absti-
nence from incarceration or treatment [9], high or
increased heroin purity [10], and injection as route of
administration [10,11]. Additional social and environ-
mental factors that mediate overdose risk include those
contextual variables such as fear of police [12], size and
quality of social networks [13], homelessness [14], public
injection [15], and recent life problems such as loss,
health problems, and financial difficulties[16] to name a
few. Popular harm reduction education messages to
reduce the risk of overdose encourage people with addic-
tion to: taste drugs before using them, do a test-shot, tour-
niquette-off for injection, use drugs in groups, buy drugs
from a trusted source, and avoid mixing drugs with simi-
lar effects. Evaluation of a cohort of injection drug users in
Vancouver found the following factors increased risk of
non-fatal overdose: cocaine and heroin injection; non-
injection opiate use; binge drug use; homelessness and
street injection; requiring help injecting; recent incarcera-
tion; and benzodiazepine, alcohol, and speedball use;
while being treated with methadone maintenance was
highly protective [17].
Population-level numbers of overdoses may fluctuate due
to a variety of factors such as variations in drug market
trends [18], police enforcement practices [17], and tem-
porally according to days of the week [19]. Although
empirical evidence is difficult to obtain, anecdotal reports
of clusters of overdoses are sometimes attributed to drug
purity, for example if drugs have been cut with noxious
substances or if drugs are exceptionally potent. An over-
dose may also occur if one drug is mistaken for another.
The infiltration of "China White" (3-methylfentanyl)
leading to outbreaks of overdoses in the US during the
1980s and 1990s illustrates these possibilities [20,21]. In
1989, San Francisco experienced 50 overdoses and 3
deaths over one weekend due to fentanyl [22]. Recently in
Vancouver a similar fatal overdose "spike" was reported
during the summer of 2005 when powdered methadone
stolen from a local pharmacy was being sold as heroin,
which caused a rash of 10 deaths within a two week
period [23]. Vancouver and other areas of Canada have no
centralized or decentralized mechanism for quickly
detecting, investigating, and addressing such an outbreak.
Instances such as these create a call for greater vigilance in
terms of monitoring overdoses and communicating risk
to the consumers of illicit drugs as well as those service
providers who work closely with people with addiction.
In order for these types of early warning systems to
become a reality and prove to be effective, a number of
elements will be required: real-time epidemiologic sur-
veillance systems for illicit drug trends and overdoses,
inter-agency networks for gathering qualitative reports
and disseminating alerts in a timely fashion, and mecha-
nisms for engaging with members of drug using commu-
nities. These elements will look different across Canada
due to the variability of provincial and municipal organi-
zation in sectors such as law enforcement and health serv-
ice delivery. In Vancouver, for example, the local health
authority has taken responsibility for gathering informa-
tion regarding drug overdoses from health services and
other sources and for issuing alerts in the community.
However, in other Canadian cities, Emergency Health
Services or other agencies may wish to adopt this role. Ide-
ally, over time governments and the various sectors could
collaborate across regional and provincial borders to
coordinate surveillance, harmonize information systems
(e.g., overdose coding and tracking) and disseminate
warnings across the country.
Current Drug Surveillance Systems Are Not Enough
Unfortunately, data surrounding drug trends and over-
dose prevalence and prevention remains fragmented,
incomplete, and untimely in Canada and elsewhere. The
US Centre for Disease Control has defined epidemiologic
surveillance as "the ongoing systematic collection, analy-
sis, and interpretation of health data essential for plan-
ning, implementation, and evaluation of public health
practice, closely integrated with the timely dissemination
of these data to those who need to know" [24]. In the case
of illicit drug trends, no such system currently exists in
Canada. The Canadian Community Epidemiologic Net-
work on Drug Use (CCENDU) [25] tracks drug use trends
in Canada using various information sources such as
cohort studies, vital statistics, Ambulance Service data,
population surveys, police crime statistics, and data from
the Coroners Service. While this provides valuable infor-
mation regarding overall past drug trends and interven-
tions in specific areas of the country, it seems to lack the
cohesion, completeness infrastructure and ability to
detect and alert people in a community to drug-related
hazards in a timely and coordinated manner.
Internationally, several surveillance systems are in place
and could inform the development of Canadian drug
information systems. However, these have limitations
with regards to providing an ongoing and timely response
mechanism that would be necessary to address an out-
break of overdoses. Surveillance systems for tracking drug
trends include drug monitoring systems in Australia,
Europe, South Africa, and the United States [19,26-30].
These use a variety of data sources such as urine and blood
specimens from adult and juvenile offenders, drug use
surveys, emergency department blood and urine toxico-Harm Reduction Journal 2007, 4:10 http://www.harmreductionjournal.com/content/4/1/10
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logical screening, key informant interviews, focus groups
and ethnographic studies. Many combine qualitative and
quantitative data to provide more complete assessment of
trends and risk. Drug purity data may be ascertained
through drugs seized by police or through consumers pro-
viding samples that they have purchased (e.g., the Nether-
land's Drug Information Monitoring System or DIMS).
Some of these organizations provide weekly or monthly
reports although much of the reporting is done on an
annual basis.
One of the more responsive systems in terms of monitor-
ing and notification of illicit drug reactions described in
the literature is the surveillance system outlined by Indig
and colleagues [32]. The authors describe the coordinated
effort of 15 emergency departments that were in operation
for the 2000 Sydney Olympics. An Olympic Coordination
Centre was established, equipped with a 24-hour phone
line and connected with various services including the
police and ambulance services. Self-report data regarding
conditions related to illicit drugs were sent electronically
within 24 hours of presentation in the emergency depart-
ments, collated and analyzed within hours, and then sent
to a committee of public health experts. This type of sys-
tem could be used to detect and potentially prevent over-
doses by identifying problems immediately when
abnormal patterns begin to appear in hospitals and com-
municating information back to consumers and other rel-
evant agencies and professionals. With the 2010
Olympics taking place in Vancouver, this strategy seems
feasible during the two week duration of the games; how-
ever, the feasibility of maintaining such a sentinel surveil-
lance system over a long period of time may be limited by
issues such as operational costs.
Despite the individual limitations of these international
surveillance systems in terms of feasibility, comprehen-
siveness, accuracy, and/or ability to provide timely infor-
mation back to communities, they illustrate possibilities
and pitfalls that can inform the development of Canadian
drug information systems. Griffith and colleagues [31]
provide a comprehensive overview of the difficulties asso-
ciated with current drug information systems and early
detection of new drug trends. They suggest that effective
drug information systems are challenged by many factors
such as sociopolitical contexts, lag-time of publications,
methodological complexity, the danger of raising false
alarms, and knowledge being "trapped" within agencies.
These factors may also hinder a rapid public health
response in communities. However, these challenges do
not necessarily preclude an early warning system for over-
doses. They highlight the need to be creative and use mul-
tiple strategies for monitoring drug trends and overdoses
and utilizing both organizational systems and human net-
works to collect and disseminate information.
Inter-agency Communication Networks are Needed
Canadian drug information systems should aim to
address overdose risk as quickly as possible by using both
quantitative and qualitative information from multiple
sectors. This includes timely access to drug testing for
information on drug quality (e.g., type and purity) and
information from authorities such as the theft of pharma-
ceuticals (e.g., from a pharmacy break-in). Including this
information in an emergency warning system could act as
a type of symptomatic surveillance system similar to mon-
itoring over the counter purchases of cold remedies to pre-
dict an outbreak of influenza before it occurs [33].
Combined qualitative and quantitative information such
as numbers of overdoses, unusual symptoms, location of
overdoses, suspicious drugs seized by police, drug-related
ambulance calls, and clinical observations in the ERs,
could be reported, collated and analyzed on a daily basis
as a front-line mechanism for rapidly detecting potential
problems. Collection of data need not be limited to a sin-
gle source such as hospitals since pooling data from all
these sources could provide a more complete picture of
the potential for an overdose outbreak. Reports from
police, ambulance, outreach workers, healthcare workers,
non-governmental organizations, general practitioners,
emergency wards, and poison control could reduce the
likelihood of information gaps and facilitate timely
assessment of risk and a public health response. Each
source of overdose information could report events (e.g.,
via telephone, fax, electronic forms, etc.) to a central loca-
tion where they could be compared to averages to identify
a potential deviation from normal. When this informa-
tion is combined with qualitative reports, experts would
be able to make decisions and disseminate and alert in
consultation with local service agencies and people with
addiction. The Canadian Adverse Drug Reaction reporting
system [34] whereby consumers, healthcare professionals,
and agencies can provide quantitative and qualitative
reports regarding side effects of legally approved drugs
and potentially activate a course of action such as issuing
consumer reports might be a useful model and an
untapped resource in the development of an early warn-
ing system for overdoses.
Community Involvement is Essential
In accordance with the goals of health promotion and
public health, representatives from marginalized popula-
tions should be enabled and empowered to improve their
own health. The Ottawa Charter, a seminal document in
Canadian health promotion policy, states that health serv-
ices should be reoriented towards promoting health and
sharing power with other sectors, other disciplines, and
"most importantly with people themselves" and that the
community should be accepted as "the essential voice in
matters of its health, living conditions and well-being"
[35]. The implications for the aforementioned system toHarm Reduction Journal 2007, 4:10 http://www.harmreductionjournal.com/content/4/1/10
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prevent overdoses include involving people with drug
addiction in both the reporting mechanism for exception-
ally hazardous substances circulating in their communi-
ties and by targeting them in the dissemination of
warnings and alerts once a threat has been detected.
Involvement of people with addiction in the planning
and implementation of such systems would be consistent
with the recently articulated position of the Canadian
Public Health Agency ("Nothing About Us Without Us")
[36]. Aside from the occasional alert that is provided to
the public through a sensationalized media, these types of
formalized systems have not been reported. Instead, infor-
mal systems are currently responsible for spreading the
warning by word of mouth through limited social net-
works and agency representatives that receive the warning
from their clients. Although skeptics may argue that peo-
ple with addiction will only use information to seek out
the offending substance and cause themselves further
harm, the scant evidence available suggests that only a
minority of users will look for drugs they perceive as more
potent [20]. Other people with addiction will likely take
precautions and this could be true even for those who try
to locate the drugs in question. The better informed that
people are of the characteristics of the substance and the
potential risks, the better able they are to make informed
choices about their drug use. Involving people with addic-
tion in the reporting and disseminating of overdose infor-
mation increases the likelihood that problems are
detected quickly and that messaging will be appropriate
and meet the needs of the community.
Although little is known about the information networks
in the drug using community, research has suggested that
users learn about drug warnings through the televised and
printed media, as well as from healthcare program staff,
and "on the street" [20,22]. Given that many drug over-
doses are never reported to emergency health services,
drug users themselves may be made aware of overdose
problems before anyone else becomes alerted to them.
Although most overdoses are witnessed by others,
bystanders will delay or neglect to seek appropriate medi-
cal assistance for reasons such as fear of arrest [37,38].
Studies indicate that many overdoses do not involve call-
ing the ambulance or going to the hospital. For example,
a recent study using data from the Vancouver Injection
Drug User Study, indicated that ambulance personnel
assisted in only 54% of non-fatal overdoses and only 57%
were taken to hospital [39]. In addition to creating an
environment that supports and enables users to seek
timely medical assistance in the case of drug overdoses,
promoting help-lines for adverse illicit drug reactions and
encouraging users to report problems to trusted commu-
nity-based organization personnel could be valuable strat-
egies. Community-based organizations may also serve as
depositories for suspected problem drugs that could
undergo testing. Such a reporting mechanism could also
represent another opportunity to connect drug users to
harm reduction services and much needed treatment
referrals.
Conclusion
In summary, given that both fatal and non-fatal overdoses
pose a significant public health concern in Canada, imple-
mentation of accurate and timely systems for monitoring
and responding to drug trends and health outcomes is
warranted. A local system including an urban area like
Vancouver would ideally involve real-time epidemiologi-
cal surveillance of drug trends and overdoses incorporat-
ing qualitative and quantitative information obtained
from institutions such as emergency health services, law
enforcement, laboratories, emergency departments, com-
munity-based organizations, research institutions and
people with addiction themselves. Targeted warnings
could be issued to various stakeholders in health, govern-
ment, and the community who could then determine
appropriate responses such as a mass public health warn-
ing, enhanced dissemination of harm reduction educa-
tion and material, or engaging in personal risk reduction
behaviours. These types of systems would complement
other Canadian strategies that have been implemented to
reduce drug-related harms such as methadone mainte-
nance therapy, supervised injection facilities, needle
exchange programs, and harm reduction education pro-
grams for people with addiction, meant to promote
health and safety in the drug using community.
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